Corrigendum: CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

Authors :: Cataldo Martucci
Andrew Dennis Allen
Nadia Moretto
Valentina Bagnacani
Alessandro Fioni
Riccardo Patacchini
Maurizio Civelli
Gino Villetti
Fabrizio Facchinetti
Source :: Frontiers in Pharmacology, Vol 15 (2024)
Publication Year :: 2024
Publisher :: Frontiers Media S.A., 2024.

Subjects :: inflammation
P38 alpha
chronic obstructive pulmonary disease
cytokines
neutrophilia
Therapeutics. Pharmacology
RM1-950

Full Text Access

Tools